Understanding Challenges And Solutions For Fda High Performance Biomedical Computing In A Ngs Era
Exploring Challenges And Solutions For Fda High Performance Biomedical Computing In A Ngs Era reveals several interesting facts. Dr. Vahan Simonyan, Ph.D. , Lead Scientist, HIVE, CBER/
Key Takeaways about Challenges And Solutions For Fda High Performance Biomedical Computing In A Ngs Era
- The presentation covers everything from moving to remote training, to tuning the cluster environment for QIIME2, to tracking the ...
- David Litwack, Ph.D., Personalized Medicine Staff,
- A webinar by Kayla Borton & Mike Shaffer (Colorado State University), the developers of the microbe/virus annotation tool for ...
- See how the United States Food and Drug Administration (
- Eunice Lee, Ph.D., Branch Chief, Division of Molecular Genetics and Pathology, OIR/CDRH/
Detailed Analysis of Challenges And Solutions For Fda High Performance Biomedical Computing In A Ngs Era
CompBioMed is a European Commission H2020 funded Centre of Excellence focused on the use and development of ... Zivana Tezak, Ph.D., Personalized Medicine Staff, OIR/CDRH/ This video provides a simple, step-by-step approach to the
This session with Dr. Khyzer focusses on clinical applications the
Stay tuned for more updates related to Challenges And Solutions For Fda High Performance Biomedical Computing In A Ngs Era.